Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 30, 2015 7:05 PM ET

Health Care Technology

Company Overview of IMS Health Holdings, Inc.

Company Overview

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, pr...

83 Wooster Heights Road

Danbury, CT 06810

United States

Founded in 1954

10,200 Employees



Key Executives for IMS Health Holdings, Inc.

Chairman, Chief Executive Officer and President
Age: 54
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice President
Age: 54
Total Annual Compensation: $457.5K
Senior Vice President of Global Services
Age: 50
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Product Management
Age: 50
Total Annual Compensation: $410.0K
Senior Vice President of Information Offerings
Age: 54
Total Annual Compensation: $402.0K
Compensation as of Fiscal Year 2014.

IMS Health Holdings, Inc. Key Developments

IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology

IMS Health and Foundation Medicine, Inc. announced a collaboration to advance the understanding and effectiveness of precision medicines for treating cancer. Commercial, medical and outcomes research teams in biopharma and life sciences companies will now be able to leverage an offering that combines IMS Health’s powerful Real-World Evidence platform providing clinical and cost-of-care insights with Foundation Medicine’s dynamic knowledgebase of comprehensive cancer genomic profiles, all at the patient-anonymous level. Through the collaboration, IMS Health’s clients will gain unprecedented insights to rapidly assess health outcomes and effectiveness, and to improve cancer care by better connecting patients to the right targeted therapies at the right time. These enhanced oncologic insights will be powered by Evidence 360 and FoundationCORE. Evidence 360 is IMS Health’s scalable and secure RWE platform that helps clients extract, analyze and visualize real-world data to better understand and measure healthcare outcomes. It brings together IMS Health’s vast library of patient-anonymous data with other patient-anonymous sources of health information to help life sciences companies interpret real-world outcomes and better target their commercial efforts. FoundationCORE is a molecular information knowledgebase containing comprehensive cancer genomic information and insights from more than 43,000 clinical cases profiled by Foundation Medicine. FoundationCORE evolves in real-time, informed by every new cancer patient tested with the company’s commercial assays, FoundationOne and FoundationOne Heme.

IMS Health Holdings, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 11:30 AM

IMS Health Holdings, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 11:30 AM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Ronald E. Bruehlman, Chief Financial Officer and Senior Vice President.

IMS Health Russia and CIS Presents at 2015 Russian Pharmaceutical Forum, May-20-2015 09:00 AM

IMS Health Russia and CIS Presents at 2015 Russian Pharmaceutical Forum, May-20-2015 09:00 AM. Venue: Corinthia Hotel, Saint Petersburg, Russia. Speakers: Nickolai Demidov, General Manager.

Similar Private Companies By Industry

Company Name Region
DocVue, Inc. United States
healthfinch Inc. United States
DrScribe, Inc. United States
Voalte, Inc. United States
Epiphany Mobile Solutions, Inc. United States

Recent Private Companies Transactions

July 22, 2015
Healthcare Data Solutions, LLC
May 5, 2015
Dataline Software Limited

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS Health Holdings, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at